Gastroenterology
Conference Coverage
AxSpA remission on TNFi seen in half of patients with comorbid IBD
Those who had IBD for less than 5 years and those taking adalimumab, as opposed to another TNFi, had higher likelihood of reaching axSpA remission...
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
News from the FDA/CDC
FDA advisory committee votes against approval for NASH drug
“Typically, in clinical practice, NASH patients are followed every 6-12 months, so more frequent monitoring would be a substantial change and may...
News from the FDA/CDC
FDA approves upadacitinib for Crohn’s disease
The approval is noteworthy because it marks the first oral small molecule treatment for CD.
From the Journals
Study explains link between fatty liver and CRC liver metastasis
Findings of a new study suggest that CRC patients with nonalcoholic fatty liver disease may respond differently to treatment than those without...
Conference Coverage
Analysis: 40% of information about cirrhosis on TikTok is incorrect
Study presented at DDW finds that patient-derived sources are usually trustworthy, promotional sources are often misleading.
Conference Coverage
Misdiagnosis, mismatch still common in pancreatic cystic neoplasms
A new study suggests that with better diagnosis a significant proportion of patients with pancreatic cystic neoplasms could be spared from surgery...
Conference Coverage
Meat heavy diets may lead to ulcerative colitis flares
Patients with ulcerative colitis and meat-heavy diets had twice as many flares as those who ate less meat.
From the Journals
How BMI over time impacts GI cancer risk
These “important findings highlight the unmet need to identify the critical time window linking adiposity and GI cancer.”
From the Journals
Statins appear to guard against liver disease progression
This study “continues the theme that cholesterol-lowering statins are good for a lot more things than just lowering cholesterol.”